Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Science
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Find Cricket Statistics
Hindi
More
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Science
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / World News / Coronavirus vaccine tracker: When will one be ready?
  • World

    Coronavirus vaccine tracker: When will one be ready?

    Siddhant Pandey
    Written by
    Siddhant Pandey
    Twitter
    Last updated on Aug 27, 2020, 08:50 pm
    Coronavirus vaccine tracker: When will one be ready?
  • The global effort to develop a vaccine against the novel coronavirus SARS-CoV-2 continues as over 24 million people have been infected worldwide.

    Even though the vaccine development process is moving at record speed, it will at least be months until a safe and effective vaccine hits the market.

    Meanwhile, let us review the progress of some of the frontrunners.

  • In this article
    Oxford-AstraZeneca vaccine Moderna vaccine Sinopharm CanSino Biologics Inc's vaccine Ad5-nCoV Russia's Sputnik V
  • #1

    Oxford-AstraZeneca vaccine

    Oxford-AstraZeneca vaccine
  • The vaccine developed by Oxford University in collaboration with the pharmaceutical firm AstraZeneca is undergoing phase 2 trials in India and phase 3 trials in other parts of the world.

    The vaccine candidate—called AZD1222 (formerly ChAdOx1 nCoV-19)—is being manufactured by the Serum Institute of India in India.

    It is expected to be ready by December 2020 with an estimated price of $4 (Rs. 295).

  • #3

    Moderna vaccine

    Moderna vaccine
  • United States biotechnology company Moderna's mRNA-1273 vaccine is also undergoing the third phase of clinical trials.

    The phase 3 trials are expected to be complete by September-end with the vaccine potentially hitting the market by the end of this year.

    Moderna has said that its vaccine will likely be priced at $32-37 (Rs. 2,300-2,700).

  • Information

    Sinopharm

  • Chinese firm Sinopharm is hoping to roll out its coronavirus vaccine candidate by the end of 2020 as well. Currently, the vaccine candidate is undergoing phase 3 trials. The potential vaccine is expected to be priced at $140 (Rs. 10,300).

  • #4

    CanSino Biologics Inc's vaccine Ad5-nCoV

  • CanSino Biologics Inc. is also developing a potential COVID-19 vaccine, called Ad5-nCOV, in association with the Beijing Institute of Biotechnology.

    Phase 3 trials are expected to start in September and the potential vaccine is expected to be launched by the end of the year.

    However, the firm has made no revelation about the price of the vaccine.

  • #5

    Russia's Sputnik V

    Russia's Sputnik V
  • Separately, Russia has claimed to have launched the first COVID-19 vaccine called Sputnik V on August 11.

    The vaccine candidate is being developed by the Gamaleya Research Institute and the Russian Defence Ministry. However, the vaccine is yet to undergo phase 3 trials.

    The vaccine is expected to be out by September-end. No announcement regarding the price has been made.

  • Oxford University
  • United States
  • Coronavirus
  • SARS-CoV-2
  • COVID-19
  •  
Latest News
  • 'Victim of political machinations,' says Zimbabwe VP amid sex scandal
    'Victim of political machinations,' says Zimbabwe VP amid sex scandal
    World
  • Delhi records warmest February day in last 15 years
    Delhi records warmest February day in last 15 years
    Delhi
  • 'Thalaivi' will clash with 'Bunty Aur Babli 2' in April
    'Thalaivi' will clash with 'Bunty Aur Babli 2' in April
    Entertainment
  • COVID-19 vaccines: SII to play huge role in mass production
    COVID-19 vaccines: SII to play huge role in mass production
    World
  • 'Spider-Man: No Way Home' is the final 'Spider-Man 3' title
    'Spider-Man: No Way Home' is the final 'Spider-Man 3' title
    Entertainment
Related Timelines
  • COVID-19 vaccine: India to produce 300 million Sputnik V doses
    COVID-19 vaccine: India to produce 300 million Sputnik V doses
    Science
  • Coronavirus: Government says it doesn't plan to vaccinate entire country
    Coronavirus: Government says it doesn't plan to vaccinate entire country
    India
  • India to produce 100 million Sputnik V doses starting 2021
    India to produce 100 million Sputnik V doses starting 2021
    Science
  • Russia's Sputnik V at least 91% effective, early data suggests
    Russia's Sputnik V at least 91% effective, early data suggests
    Science
Trending Topics
Joe Biden Coronavirus
Next News Article
Share
Cancel

Want to share it with your friends too?

Facebook Whatsapp Twitter Linkedin
Copied

Love World news?

Subscribe to stay updated.

World Thumbnail
India News Business News World News Politics News Sports News Science News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Bharti Airtel Mukesh Ambani Indian Premier League Samsung Virat Kohli Rohit Sharma
Cricket News Narendra Modi Facebook YouTube Hollywood News WhatsApp Bollywood News ISRO Rahul Gandhi Yoga
Honda Batman Football News BMW Vaccine Reliance Jio OPPO Amazon Food News, Healthy Recipes Royal Challengers Bangalore
Toyota Fashion Tips Farmers Protest Mercedes Isha Ambani India Vs England Cricket OnePlus Mobiles Android TV Smart TV Marvel Comics
Avengers Neha Kakkar Premier League Big Bang Theory
About Us Privacy Policy Terms & Conditions Contact Us News Reviews News Archive Topics Archive Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2021